Isabel Portela Moreira, Paula Serrão, Lucinda Sequeira, Maria José Sá, Maria Augusta Vieira-Coelho, Joana Guimarães
{"title":"Relationship between cerebrospinal fluid catecholamines levels and biomarkers of Alzheimer's disease, inflammation and neuronal injury.","authors":"Isabel Portela Moreira, Paula Serrão, Lucinda Sequeira, Maria José Sá, Maria Augusta Vieira-Coelho, Joana Guimarães","doi":"10.1080/01616412.2025.2542944","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Changes in the locus coeruleus are among the earliest events in Alzheimer's disease (AD). We aimed to evaluate the relationship between cerebrospinal fluid (CSF) L-dihydroxyphenylalanine (L-DOPA), dopamine, and norepinephrine with CSF biomarkers of AD pathology (β-amyloid and p-tau), neuronal destruction (neurofilaments), and inflammation (leukocytes, IgG index, interleukin-6 and 10).</p><p><strong>Methods: </strong>We conducted a cross-sectional, observational study, including 35 patients with AD, 16 with frontotemporal dementia, and 38 normal controls (NC).</p><p><strong>Results: </strong>L-DOPA was lower (<i>p</i> = 0.032) and neurofilaments were higher (<i>p</i> = 0.005) in AD than in NC. Norepinephrine levels were positively correlated with age (<i>r</i> = 0.260, <i>p</i> = 0.015 among all patients). L-DOPA levels were negatively correlated with neurofilaments (<i>r</i> = -0.228, <i>p</i> = 0.038 among all participants). Interleukin-6 was positively correlated with L-DOPA (<i>r</i> = 0.382, <i>p</i> = 0.026) and norepinephrine (<i>r</i> = 0.485, <i>p</i> = 0.004) levels in AD.</p><p><strong>Conclusion: </strong>Since neurofilaments are associated with neuronal damage, decreased L-DOPA levels in AD could be related to neuronal destruction. Catecholaminergic dysregulation seen in AD seems independent of β-amyloid and p-tau pathology.</p>","PeriodicalId":19131,"journal":{"name":"Neurological Research","volume":" ","pages":"1-11"},"PeriodicalIF":1.5000,"publicationDate":"2025-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurological Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/01616412.2025.2542944","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Changes in the locus coeruleus are among the earliest events in Alzheimer's disease (AD). We aimed to evaluate the relationship between cerebrospinal fluid (CSF) L-dihydroxyphenylalanine (L-DOPA), dopamine, and norepinephrine with CSF biomarkers of AD pathology (β-amyloid and p-tau), neuronal destruction (neurofilaments), and inflammation (leukocytes, IgG index, interleukin-6 and 10).
Methods: We conducted a cross-sectional, observational study, including 35 patients with AD, 16 with frontotemporal dementia, and 38 normal controls (NC).
Results: L-DOPA was lower (p = 0.032) and neurofilaments were higher (p = 0.005) in AD than in NC. Norepinephrine levels were positively correlated with age (r = 0.260, p = 0.015 among all patients). L-DOPA levels were negatively correlated with neurofilaments (r = -0.228, p = 0.038 among all participants). Interleukin-6 was positively correlated with L-DOPA (r = 0.382, p = 0.026) and norepinephrine (r = 0.485, p = 0.004) levels in AD.
Conclusion: Since neurofilaments are associated with neuronal damage, decreased L-DOPA levels in AD could be related to neuronal destruction. Catecholaminergic dysregulation seen in AD seems independent of β-amyloid and p-tau pathology.
期刊介绍:
Neurological Research is an international, peer-reviewed journal for reporting both basic and clinical research in the fields of neurosurgery, neurology, neuroengineering and neurosciences. It provides a medium for those who recognize the wider implications of their work and who wish to be informed of the relevant experience of others in related and more distant fields.
The scope of the journal includes:
•Stem cell applications
•Molecular neuroscience
•Neuropharmacology
•Neuroradiology
•Neurochemistry
•Biomathematical models
•Endovascular neurosurgery
•Innovation in neurosurgery.